Gritstone bio announced that the Compensation Committee of the company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 20,000 shares of its common stock with an exercise price of $2.76, which is equal to the closing price of Gritstone’s common stock on April 3, 2023, the date of the grant. These stock options are part of an inducement material to the new employee becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options will vest over a four-year period, with 25% of the options vesting on the first anniversary of the employees’ date of hire, and 1/48th of the options vesting monthly thereafter, subject to the employees’ continued employment with Gritstone on such vesting dates. The stock options are subject to the terms and conditions of Gritstone’s 2021 Employment Inducement Incentive Award Plan and the stock option agreement covering the grant.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GRTS:
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023
- Gritstone initiated with an Outperform at Evercore ISI
- Gritstone initiated with a Buy at B. Riley
- Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting